Prana Biotechnology announced that it has secured a key PBT2 patent in Japan. The Japanese Patent Office has granted a composition of matter patent for Prana’slead clinical asset, PBT2 and other selected 8-Hydroxyquinoline compounds in Japan. The patent entitled ‘8-Hydroxyquinoline derivatives’ also covers pharmaceutical compositions containing PBT2 and selected 8- hydroxyquinoline compounds and the use of the compounds for the treatment of Alzheimer’s Disease. :theflyonthewall.com
News For PRAN From The Last 14 Days
Check below for free stories on PRAN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
